ArticleTherapeutics and clinical risk management2014

Cost-effectiveness analysis on the use of rFSH + rLH for the treatment of anovulation in hypogonadotropic hypogonadal women.

Enrico Papaleo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.